James Helliwell
Fortuna: 7 M $ al 31/07/2026
Fortuna: 7 M $ al 31/07/2026
James A. Helliwell is the founder of Eupraxia Pharmaceuticals, Inc., founded in 2011, where Dr. Helliwell holds the titles of Chief Executive Officer & Director.
Dr. Helliwell is also the founder of Accuro Technologies, Inc...
Dr. Helliwell is currently the Chairman at Guidestar Medical Devices.
Formerly, Dr. Helliwell was an Assistant Professor at the University of British Columbia.
Dr. Helliwell completed undergraduate education at the University of British Columbia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/06/2026 | 1.055.012 ( 1,61 % ) | 7 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Fundador | 12/05/2011 |
Guidestar Medical Devices
Guidestar Medical Devices Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Presidente | - |
Accuro Technologies, Inc. | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accuro Technologies, Inc. | |
Guidestar Medical Devices
Guidestar Medical Devices Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.